Actions of IGFBP on epithelial cancer cells: potential for new therapeutic targets.
Perks
C
C
Division of Surgery, Department of Hospital Medicine, Bristol Royal Infirmary, Bristol, UK. ClaireM.Perks@bristol.ac.uk
Holly
J
J
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002455:Cell Division / Q000187:drug effects; D004847:Epithelial Cells / Q000187:drug effects / Q000473:pathology*; D006801:Humans; D018969:Insulin-Like Growth Factor Binding Proteins / Q000627:therapeutic use*; D009369:Neoplasms / Q000473:pathology*; D013002:Somatomedins / Q000502:physiology
D000970:Antineoplastic Agents; D018969:Insulin-Like Growth Factor Binding Proteins; D013002:Somatomedins